ESCRS - POCAT378 - Patient Reported Outcomes Following Vivity Increased Range Of Focus Intraocular Lens Implantation In Routine Cataract And Lens Exchange Surgery

Patient Reported Outcomes Following Vivity Increased Range Of Focus Intraocular Lens Implantation In Routine Cataract And Lens Exchange Surgery

Published 2026 - 44th Congress of the ESCRS

Reference: POCAT378 | Type: Free paper | DOI: 10.82333/nkmd-h716

Authors: Prof. Mohammed Muhtaseb* 1 , Dr Amber Khattak 2

1Sulaymaniyah University,Sulaymaniyah,Iraq;iLase Private Practice,Cardiff,United Kingdom;Hebron University,Hebron,Palestinian, State of, 2iLase Private Practice,Cardiff,United Kingdom

Purpose

To assess post-operative visual acuity and patient-reported outcomes following cataract surgery with implantation of the Vivity increased range of focus intraocular lens, and to evaluate dysphotopsia, functional vision, and patient satisfaction in a real-world setting.

Setting

Single surgeon clinic with retrospective audit performed for routine cataract surgery.

Methods

Patients undergoing cataract surgery with implantation of the Vivity intraocular lens (DFT015, DFTx15, CNWET0, CNWET2–6) were retrospectively reviewed. Unaided distance, intermediate, and near visual acuity outcomes were analysed. Patient-reported outcomes included satisfaction with surgery, willingness to repeat the procedure, functional vision at different distances, and dysphotopsia symptoms. Dysphotopsia frequency was analysed by grouping responses into “always/most of the time” and “some of the time/never” categories among recorded responses.

Results

A total of 584 eyes implanted with the Vivity lens were included, and 34% of these had a guarded prognosis.  Patient-reported satisfaction was high, with the majority of respondents indicating willingness to repeat surgery, and surgical outcomes were reported as fully or mostly matching expectations by 97.3%. Among patients reporting dysphotopsia, glare was infrequently experienced, 10% , while halos and starbursts were reported variably, 5% each. 83.5%(117/140) of patients described spectacle independence for distance and 87%(120/138) for intermediate vision, with variable need for reading glasses, with 48.2% (67/138) patients never needing them, and 31.7%(44/138) needing them only some of the time.

Conclusions

Alcon Vivity intraocular lens implantation demonstrated favourable real-world visual outcomes and high patient satisfaction. Dysphotopsia symptoms were generally infrequent. These results support the use of Vivity as an increased range of focus lens option and emphasises the need for comprehensive patient-reported outcome collection in routine practice.